The antibacterial activities of the fluorinated 4-quinolones (e.g., ciprofloxacin) have been ascribed to a marked inhibition of bacterial DNA gyrase. In contrast, the influence on purified mammalian DNA enzymes, including topoisomerases, has been reported to be several orders of magnitude weaker, occurring at concentrations higher than 100 ,ug of ciprofloxacin per ml. In this study, using a nondenaturing filter elution method, a marked induction of double-strand DNA breaks in human lymphoblastoid cells exposed to 80 ,ug of ciprofloxacin per ml was seen. The proportion of single-strand versus double-strand DNA breaks was similar to that seen with the topoisomerase II inhibitory antitumor agent VP-16. The cellular recovery was more rapid after treatment with ciprofloxacin than after treatment with VP-16, displaying a normal elution profile within 15 min at 37°C (60 min for VP-16). These data indicate that ciprofloxacin has an effect on intracellularly located topoisomerase H in humans.The antibacterial activities of fluorinated 4-quinolones have been ascribed to the binding of these drugs to DNA (12), leading to a marked inhibition of bacterial DNA gyrase (6). In contrast, the influence on mammalian DNA topoisomerases is several orders of magnitude weaker, as measured by a purified eukaryotic topoisomerase II (topo II) plus plasmid DNA assay (5,8). In those studies an inhibitory influence on the catalytic function of topo II by ciprofloxacin was noted at minimally effective concentrations of 140 ,ug/ml (5) or 150 ,ug/ml (8). Also, topo II-dependent DNA breakage has been assayed by using a plasmid system; cleavage of nonradioactively labeled plasmid DNA was not seen at ciprofloxacin levels up to 1,000 ,ug/ml, whereas in a more sensitive assay with radioactively labeled plasmid, cleavage was observed at 120 ,ug/ml (5).In the present study we investigated the effects of ciprofloxacin on intracellularly located topo II using a human lymphoblastoid cell system. The previously reported (3) cellular DNA breakage associated with ciprofloxacin was determined to be due mainly to the introduction of doublestrand DNA breaks (DSBs), indicating a causative role of topo 11 (13). The proportion of single-strand DNA breaks (SSBs) versus DSBs was similar to that seen with the epipodophyllotoxin antitumor agent 14). However, the cellular recovery from the DNA damage was more rapid with ciprofloxacin than with VP-16, displaying a normal elution profile within 15 min at 37°C (60 min for VP-16).MATERIALS AND METHODS Drugs. Fresh solutions of preservative-free ciprofloxacin (Bayer, Wuppertal, Federal Republic of Germany) were used. Etoposide (VP-16) was obtained from Bristol-Myers (Syracuse, N.Y.) as a concentrated solution for infusion (20 mg/ml).UV irradiation. A total of 106 cells suspended in 4 ml of phosphate-buffered saline (pH 7.4) in a 5-cm-diameter plastic dish were exposed (dish lid off) to radiation from an ordinary laboratory hood UV tube (GTE Sylvania G30 T8) emitting 1.0 W of UVC per m2 at a distance of about 30 cm (as * ...